Company Description
Aeolus Pharmaceuticals, Inc. Formerly known as Incara Pharmaceuticals, Inc.. The Group's principal activities are to develop a series of catalytic antioxidant molecules which protect against the damaging effects of reactive oxygen derived molecules. ...
Related Business Topics
Breaking News
Reuters - November 05, 2009 7:10 AM
MISSION VIEJO, Calif.--(Business Wire)-- Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today the presentation of data at the GHSI Public Health Emergency Medical Countermeasures Workshop detailing the potential of AEOL 10150 as a broad spectrum ...
Reuters - November 04, 2009 11:56 AM
Data Supports Compound's Potential as a Countermeasure for Chlorine Gas Exposure MISSION VIEJO, Calif.--(Business Wire)-- Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) reported that researchers from National Jewish Health and McGill University have ...
Forbes.com - November 04, 2009 11:01 AM
Reuters - September 11, 2009 7:33 AM
MISSION VIEJO, Calif.--(Business Wire)-- Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has submitted a white paper to the Biomedical Advanced Research and Development Authority (BARDA) in response to Special Instructions Amendment 4 ...
Forbes.com - September 11, 2009 6:55 AM
, 9:00 AM ET BusinessWire - Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has submitted a white paper to the Biomedical Advanced Research and Development Authority (BARDA) in response to Special Instructions Amendment 4 to a Broad ...
